Show Notes
In this episode, host Dr Sean Stevens is joined by Dr Paul Effler, Senior Medical Advisor at the WA Department of Health and Adjunct Dr at the University of Western Australia. Dr Effler is an experienced public health physician with extensive expertise in vaccine safety surveillance and has been a longstanding member of the WHO Global Advisory Committee for Vaccine Safety. They explore the use of intranasal vaccines for influenza and COVID-19, which are now available in Australia. Dr Effler explains the mechanistic advantages of intranasal vaccines compared to traditional intramuscular injections, highlighting their ability to create mucosal immunity at the site where respiratory pathogens enter the body. Offering the dual possibility of preventing both clinical infection and onward transmission which is a key public health benefit. Practical aspects of administering intranasal vaccines in general practice are discussed, including ease of use, absence of sharps and associated risks, and specific technique considerations. Looking ahead, they also covered potential future developments in intranasal immunisation, including vaccines for RSV and pertussis, and the promise of platforms that do not rely on live attenuated virus. Dr Effler describes emerging models of self-administration and the possible implications for increasing vaccine uptake, while reaffirming the ongoing role of GPs in supporting safe and effective immunisation. The Good GP Podcast is a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at www.talkinghealthtech.com/podcast/network If you have any questions or would like to contact The Good GP, send an email to [email protected]. Visit www.thegoodgp.com.au for previous episodes and more information.
More from The Good GP
In this episode of The Good GP, Dr Krystyna de Lange speaks with Dr Steph Daly, GP with a special interest in aged care and dementia, about the introduction of plasma biomarkers, specifically the p-Tau 217 blood test for Alzheimer’s disease. They explore what the p-Tau 217 test measures, its reliability, and its role in primary care.
In this episode of The Good GP, host Dr Krystyna De Lange speaks with Dr David Leitinger, a GP with a special interest in addiction medicine, about the practical use of naltrexone for managing alcohol use disorder (AUD).
In this episode of The Good GP, Dr Julia Rawlinson speaks with Dr Florence Martin, an epidemiologist specialising in pregnancy pharmacoepidemiology. Dr Martin discusses her recent study examining the relationship between first trimester antidepressant use and miscarriage risk, using UK primary care data from the CPRD GOLD database.
In this episode of the Good GP, Dr Julia Rawlinson speaks with Dr Julia Feutrill, consultant psychiatrist at King Edward Memorial Hospital and co-director of the Elizabeth Clinic. They discuss the complexities of antidepressant use during pregnancy, providing GPs with practical advice for navigating these conversations.
In this episode of the Good GP, Dr Julia Rawlinson speaks with Dr Paul Effler, Senior Medical Advisor at the WA Department of Health and expert in communicable diseases, about H5N1 avian influenza and pertussis.